Market open
Aileron Therapeutics Inc./$RNTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aileron Therapeutics Inc.
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
Ticker
$RNTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
15
Website
RNTX Metrics
BasicAdvanced
$36M
-
-$2.13
2.34
-
Price and volume
Market cap
$36M
Beta
2.34
52-week high
$2.50
52-week low
$1.50
Financial strength
Current ratio
3.302
Quick ratio
3.119
Management effectiveness
Return on assets (TTM)
-31.63%
Return on equity (TTM)
-54.95%
Valuation
Price to book
0.71
Price to tangible book (TTM)
-1.01
Price to free cash flow (TTM)
-0.807
Growth
Earnings per share change (TTM)
-25.14%
3-year earnings per share growth (CAGR)
-30.58%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Aileron Therapeutics Inc. stock?
Aileron Therapeutics Inc. (RNTX) has a market cap of $36M as of April 08, 2025.
What is the P/E ratio for Aileron Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Aileron Therapeutics Inc. (RNTX) stock is 0 as of April 08, 2025.
Does Aileron Therapeutics Inc. stock pay dividends?
No, Aileron Therapeutics Inc. (RNTX) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next Aileron Therapeutics Inc. dividend payment date?
Aileron Therapeutics Inc. (RNTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Aileron Therapeutics Inc.?
Aileron Therapeutics Inc. (RNTX) has a beta rating of 2.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.